Fujian Comhony Biotechnology

Fujian Comhony Biotechnology is a high-end biomedical enterprise based in Fuzhou, China, specializing in the research, development, and production of active pharmaceutical ingredients (APIs) and nutraceuticals. Founded in 2017 as a subsidiary of the Comward Group, the company utilizes fermentation and semi-synthetic technologies to manufacture a range of products, including dermatological antibiotics like mupirocin and fusidic acid, as well as advanced injectable antibiotics such as daptomycin and dalbavancin. Additionally, Comhony produces high-quality nutraceutical ingredients like PQQ and ergothioneine focused on mitochondrial health and anti-aging. The company's manufacturing facilities are GMP-certified and have received approvals from the US FDA and EDQM, serving a global market across the pharmaceutical and dietary supplement industries.